Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-year Strong growth in key commercial metrics, including prescriber base, fill rates, and patient enrollments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback